The Lancet Diabetes & Endocrinology

The Lancet Diabetes & Endocrinology, dedicated to covering the disciplines of diabetes, endocrinology, and metabolism, is the latest title in The Lancet family of specialty journals. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Diabetes & Endocrinology will contain Original Research, Reviews, Comments, and News. The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks on average of submission and published Online First on TheLancet.com before the print issue.

Publisher
Lancet

Some content from Wikipedia, licensed under CC BY-SA

Health

Smoking linked with higher risk of type 2 diabetes

Current smokers and people regularly exposed to second-hand smoke have a significantly increased risk for type 2 diabetes compared with people who have never smoked, according to a new meta-analysis conducted by researchers ...

Diabetes

Well-known drug has less risk for preterm delivery in PCOS

Metformin can halve the risk of late miscarriage and preterm births for women with polycystic ovary syndrome (PCOS). PCOS occurs in 10 to 15 percent of all women. The symptoms are irregular menstrual periods, increased levels ...

Alzheimer's disease & dementia

Does midlife obesity protect against dementia?

People who are obese in middle age run a lower risk of developing dementia later, said a large and long-term study Friday whose findings challenge the prevailing wisdom.

page 1 from 7